{"filing":{"accession_number":"0001628280-26-052149","cik":"0001725255","ticker":"AHCO","company_name":"AdaptHealth Corp.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"ahco-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1725255/000162828026052149/ahco-20260804.htm"},"events":[{"id":24019,"run_id":21726,"accession_number":"0001628280-26-052149","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"AdaptHealth issued a press release on August 4, 2026, announcing financial results for the quarter ended June 30, 2026, disclosing Q2 net revenue of $740.3 million (up 12.7%), organic revenue growth of 15.9%, and a net loss of $145.3 million (largely due to a $144.2 million goodwill write-down). The filing also includes revised full-year 2026 guidance for net revenue, Adjusted EBITDA, and free cash flow. This is a standard quarterly earnings disclosure furnished under Item 2.02.","company_name":"AdaptHealth Corp.","ticker":"AHCO","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":24401,"accession_number":"0001628280-26-052149","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"AdaptHealth issued a press release on August 4, 2026, announcing financial results for the quarter ended June 30, 2026, disclosing Q2 net revenue of $740.3 million (up 12.7%), organic revenue growth of 15.9%, and a net loss of $145.3 million (largely due to a $144.2 million goodwill write-down). The filing also includes revised full-year 2026 guidance for net revenue, Adjusted EBITDA, and free cash flow. This is a standard quarterly earnings disclosure furnished under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:39:00.703757+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24401,"accession_number":"0001628280-26-052149","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"AdaptHealth issued a press release on August 4, 2026, announcing financial results for the quarter ended June 30, 2026, disclosing Q2 net revenue of $740.3 million (up 12.7%), organic revenue growth of 15.9%, and a net loss of $145.3 million (largely due to a $144.2 million goodwill write-down). The filing also includes revised full-year 2026 guidance for net revenue, Adjusted EBITDA, and free cash flow. This is a standard quarterly earnings disclosure furnished under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:39:00.703757+00:00","company_name":"AdaptHealth Corp.","ticker":"AHCO","filing_date":"2026-08-04"}]}